EU Commission provides further 1.5 million Euro to help tackle Marburg outbreak in Angola

The European Commission has approved a second emergency decision in response to the Marburg epidemic in northern Angola. The outbreak of this rare viral haemorrhagic fever has by now become the worst ever recorded of the disease. It is also the first time that cases have been diagnosed in an urban environment.

There is unfortunately no specific treatment for Marburg, but supportive hospital therapy and barrier nursing techniques to prevent direct contact with the patient must be provided.

The aid is being managed by ECHO, the Commission’s Humanitarian Aid department, which comes under the responsibility of Commissioner Louis Michel. Mr Michel said: “The Marburg fever is extremely worrying because it is so contagious and virulent. That is why we have decided to fund essential health work to help stem the spread of the virus. At the same time it is important to provide reliable information about who is at risk and how it is spread, in order to prevent unnecessary panic and stigmatisation of victims.”

This decision will cover a series of measures including special equipment to protect health workers, essential relief items such as blankets and water containers, medicines such as antibiotics, clean water, air transport of medical staff and supplies to the affected locations, community emergency education/information and support for quarantine and other public health measures. The funds come in addition to €500,000 channelled by the Commission on 24 March through Médecins Sans Frontières (MSF) Spain and Holland - see IP/05/381.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New toolkit aims to help U.S. hospitals spot deadly viral hemorrhagic fevers faster and safer